Cargando…
Urinary Zinc Loss Identifies Prostate Cancer Patients
SIMPLE SUMMARY: Prostate cancer is known to lose the capability to absorb and secrete zinc compared to normal prostate tissue, suggesting that the evaluation of zinc in prostate secretion can be a tool to identify the risk of developing cancer. In our study, we observed that the average amount of zi...
Autores principales: | Maddalone, Maria Grazia, Oderda, Marco, Mengozzi, Giulio, Gesmundo, Iacopo, Novelli, Francesco, Giovarelli, Mirella, Gontero, Paolo, Occhipinti, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656408/ https://www.ncbi.nlm.nih.gov/pubmed/36358735 http://dx.doi.org/10.3390/cancers14215316 |
Ejemplares similares
-
Low Levels of Urinary PSA Better Identify Prostate Cancer Patients
por: Occhipinti, Sergio, et al.
Publicado: (2021) -
DKK-1 in prostate cancer diagnosis and follow up
por: D’Amelio, Patrizia, et al.
Publicado: (2014) -
Exploring chitosan-shelled nanobubbles to improve HER2 + immunotherapy via dendritic cell targeting
por: Argenziano, Monica, et al.
Publicado: (2022) -
Safety and Feasibility of Transperineal Targeted Microwave Ablation for Low- to Intermediate-risk Prostate Cancer
por: Oderda, Marco, et al.
Publicado: (2022) -
mEPE-score: a comprehensive grading system for predicting pathologic extraprostatic extension of prostate cancer at multiparametric magnetic resonance imaging
por: Gatti, Marco, et al.
Publicado: (2022)